Marine biotech industry could grow by 12 percent per year
Scientists say innovation inspired by sea life is essential to tackling Europe's grand challenges
Europe can become a global leader in marine biotechnology within 10 years, according to a new report from the Marine Board of the European Science Foundation. Marine biotech currently represents a 2.8 billion euro market globally, with potential to grow up to 12% annually if industry and academics work together.
Europe's four seas and two oceans provide a huge variety of conditions of temperature, pressure, light and chemistry, from shallow coastal waters to the deep ocean. The adaptations which have enabled marine organisms to thrive in these conditions have resulted in a living library of diversity which is largely unexplored and underexploited. Marine biotechnologists can develop new products and services based on these resources that can contribute to addressing critical future challenges such as a sustainable supply of food and energy, development of new drugs and health treatments, and providing new industrial materials and processes.
"Marine biotechnology not only creates jobs and wealth, it can also contribute to the development of greener, smarter economies," said Lars Horn of the Research Council of Norway and Chair of the Marine Board. "Japan, China and the USA are already investing heavily in marine biotechnology. If we fail to act, Europe will lose out."
Biofuels are just one example of how marine biotech can help deliver the Europe 2020 strategy: cultivating microalgae for fuel could reduce greenhouse gas emissions by 20%. This technology is perhaps the most promising way of harnessing the ocean's bioenergy, but needs more in-depth research to cut costs and increase production.
Europe's waters also offer a potential source of drugs, biomaterials and industrial products such as biopolymers. More than 13 marine-derived treatments are already in clinical development, many targeting cancer. There is also scope for marine biotech to further improve the capacity of aquaculture to meet Europe's growing demand for sustainable, healthy seafood.
The recently published Marine Board position paper "Marine Biotechnology: A New Vision and Strategy for Europe" provides a roadmap for European research in this field and sets out an ambitious but achievable science and policy agenda for the next decade. The Marine Board predicts that with the right actions taken now, Europe could be a world leader in the field of marine biotechnology by 2020. The actions needed are:
- developing new research strategies and programmes for marine biotechnology, aligned across the national, regional and pan-European levels
- improving the technology transfer pathways to strengthen collaboration between academic research and industry
- securing a fair and equitable access to marine genetic resources to support European innovation in this growing area
- creating a stronger identity and communicating to raise awareness of European marine biotechnology research
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
Lidocaine
FDA grants Orphan Drug Status to Allon’s davunetide for brain disease
WACKER Expands Production Capacity for Biopharmaceuticals in San Diego - Wacker Biotech US is expanding its mRNA and protein production
